Pfizer and biontech publish preclinical data from investigational covid-19 vaccine program in nature

New york, ny and mainz, germany, february 1, 2021 (globe newswire) — pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced that preclinical data in non-human primate and mouse models from pfizer and biontech's mrna-based vaccine candidates, bnt162b1 and bnt162b2, for the prevention of covid-19 were published in the journal nature . some of these data were initially made available to the public on september 9, 2020 via the online preprint server, biorxiv . for additional details, please read the previously issued press release .
BNTX Ratings Summary
BNTX Quant Ranking